It's confirmed: Amarin loses Vascepa patent appeal, putting generics defense on life support | Fierce Pharma
Novartis Sues to Block Generic Sales of Top Drug Gilenya for MS - Bloomberg
natco: Patent infringement lawsuit filed against Natco by Johnson & Johnson, Momenta - The Economic Times
FiercePharmaAsia—Takeda's workforce rejig and Velcade patent win, China's insurance drug list | Fierce Pharma
Novartis loses in patent appeal over multiple sclerosis drug Gilenya | The Financial Express
Stampeding generics expected to trample Lilly's now-off-patent ADHD med Strattera | Fierce Pharma
Biogen takes another blow as appeal for Tecfidera patent revival falls short | Fierce Pharma
Facing 'imminent' Gilenya generics and a $300M sales hit, Novartis takes patent fight to Supreme Court | Fierce Pharma
Novartis dealt another blow in ongoing Gilenya patent feud
Novartis dodges Gilenya kickback claims—again
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4SADGYNDOJLEBHXQYSBDSEA5AI.jpg "Novartis loses in patent appeal over multiple sclerosis drug | Reuters")
Novartis loses in patent appeal over multiple sclerosis drug | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UQPIK3T2DVOX7EIO4QZCM5HIAA.jpg "Novartis loses in patent appeal over multiple sclerosis drug | Reuters")
Novartis loses in patent appeal over multiple sclerosis drug | Reuters
Novartis could snag a blockbuster MS market all for itself, just in time to fight Gilenya generics | Fierce Pharma
Alembic Pharma gets USFDA approval for hypertension drug - Elets eHealth
Alembic Pharma: How to win the US: Alembic Pharma will have to crack the complex-products game - The Economic Times
Novartis wins Supreme Court temporary reprieve on Gilenya generics (NYSE:NVS) | Seeking Alpha
Novartis' Gilenya tops Teva giant Copaxone in head-to-head MS study | Fierce Pharma
Johnson & Johnson, Momenta Pharma File Patent Infringement Lawsuit Against Natco, Mylan in US for Glatiramer Acetate Injection. | News & Updates
Lilly fends off Cialis generics with new patent settlement | Fierce Pharma
Alembic Pharma (Oral Solids ==> Injectables, Onco, Derma, Opthalmic) - Not-so-Hidden Gems - ValuePickr Forum
After win at patent office, Bristol Myers inks Revlimid deal with Dr. Reddy's | Fierce Pharma
/cloudfront-us-east-2.images.arcpublishing.com/reuters/S2ZVV3DI4ZIZHAUZZLLFYCSR6Y.jpg "U.S. Supreme Court grants Novartis request to halt Gilenya generic rivals | Reuters")
U.S. Supreme Court grants Novartis request to halt Gilenya generic rivals | Reuters
Riding on patent office win, Novartis takes Gilenya generics fight to court | Fierce Pharma
Novartis Sues to Block Generic Sales of Top Drug Gilenya for MS - Bloomberg
